Pacific Biosciences of California (NASDAQ:PACB) is one of today's best performing low-priced stocks, up 6.6% to $1.45 on 1.2x average daily volume. Pacific Biosciences of California has traded 380,000 shares thus far today, vs. average volume of 324,000 shares per day. The stock has outperformed the Dow (6.6% to the Dow's 1.3%) and outperformed the S&P 500 (6.6% to the S&P's 1.3%) during today's trading.
Pacific Biosciences of California Inc. has developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. The Company's system enables real-time analysis of biomolecules with single molecule resolution.
Pacific Biosciences of California has overhead space with shares priced $1.45, or 31.5% below the average consensus analyst price target of $2.12. Pacific Biosciences of California shares should first meet resistance at the 50-day moving average (MA) of $1.70 and find additional resistance at the 200-day MA of $2.59.
In the past 52 weeks, shares of Pacific Biosciences of California have traded between a low of $1.06 and a high of $5.27 and are now at $1.45, which is 37% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 2% while the 200-day MA has slid 1.3%.